Clover Health Investments, Corp. Earnings Recaps
Q1 2026
May 9, 2026
Shares jumped 16.4% post-earnings, reflecting investor approval of Clover Health's 51% year-over-year membership growth and return to GAAP net income profitability, underscoring confidence in the company’s tech-driven care model and scalable Medicare Advantage platform.
Key takeaways
- Membership increased 51% year-over-year, driven primarily by growth in core New Jersey PPO markets.
- GAAP net income returned to positive $27 million this quarter, signaling improved financial discipline and operating leverage.
- Over one-third of members received Clover Assistant-powered care, supporting the company’s targeted clinical engagement strategy.
- Management moderated in-year growth to prioritize clinical integration, aiming for sustainable cohort economics versus short-term expansion.
- Positioned well for 2027 with CMS maintaining stable risk adjustment and favorable regulatory changes supporting encounter-based documentation.
Q3 2025
Nov 6, 2025
Clover Health's Q3 2025 results reflect strong membership growth of 35% and revenue increase of nearly 50% year-over-year, but adjusted EBITDA profitability fell short due to higher than expected new member acquisition costs.
Key takeaways
- Sustained profitable growth despite missing adjusted EBITDA targets, attributed to increased new member dilution.
- Continued strong performance of Clover Assistant, leading to top HEDIS clinical quality scores in the PPO segment.
- Full-year outlook revised to expect 44,000 new members, with profitability projected to improve significantly in 2026.
- Focused refocus on managing new member utilization through enhanced Clover Assistant engagement.
- Strong retention rates expected to drive returning member profitability and support long-term growth strategy.